P11 Proton pump inhibitors are associated with reduced response to infliximab in inflammatory bowel disease

Abstract

IntroductionInfliximab is a first line treatment for moderate-severe inflammatory bowel disease (IBD). Proton pump inhibitors (PPI) are frequently over-prescribed. They modify the gut microbiome and a recent meta-analysis of randomised...